Halozyme Therapeutics

HALO | NASDAQ | 1 Followers
$60.08 +1.74% $1.03
Follow
Overview Metrics Financials
Loading...

Fair Price

$29.45
Undervalued by 46.8%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Halozyme Therapeutics, Inc. is a U.S.-based biotechnology company focused on developing innovative therapeutic agents and technologies that improve drug absorption. Founded in 1998 and headquartered in San Diego, California, Halozyme is best known for its Enhanze™ platform, which uses enzymes to accelerate the absorption of biologic drugs, enabling them to be administered in lower doses or over shorter periods. The company collaborates with numerous pharmaceutical and biotechnology firms to develop new therapeutic products.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade